Study on the plasma protein binding rate of Schisandra lignans based on the LC-IT-TOF/MS technique with relative quantitative analysis

Chinese Journal of Natural Medicines

Volumn 11, Issue 4, 2013, Pages 442-448

  Liang, Yan ^a   Zhou, Yuan Yuan ^a   Liu, Yan Na ^a   Guan, Tian Ye ^a   Zheng, Xiao ^a   Dai, Chen ^a   Xing, Lu ^a   Rao, Tai ^a   Xie, Lin ^a   Wang, Guang Ji ^a  

^a China Pharmaceutical University   (China)

Author keywords

LC IT TOF MS; Protein binding ratio; Schisandra chinensis extract; Schisandra lignans

Indexed keywords

GOMISIN A; LIGNAN; PLASMA PROTEIN; SCHISANDRA CHINENSIS EXTRACT; SCHISANTHERIN; SCHIZANDRIN; SCHIZANDRIN B; SCHIZANDROL A; UNCLASSIFIED DRUG;

ARTICLE; CALIBRATION; DOG; EXPOSURE; HUMAN; LIQUID; LIQUID CHROMATOGRAPHY; MICROFILTRATION; NONHUMAN; PLASMA; PLASMA PROTEIN BINDING; QUANTITATIVE ANALYSIS; RAT; SCHISANDRA; STANDARD; TIME OF FLIGHT MASS SPECTROMETRY;

EID: 84880000902     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(13)60066-7     Document Type: Article

References (16)

1. Mehvar R Role of protein binding in pharmacokinetics[J]. Am J Pharm Educ 2005, 69(5). article 1526.
2. Wagner J History of pharmacokinetics[J]. Pharmacol Ther 1981, 12:537-562.
3. Benet L, Hoener B Changes in plasma protein binding have little clinical relevance[J]. Clin Pharmacol Ther 2002, 71(3):115-121.
4. Lombardo F, Obach RS, Shalaeva MY, et al. Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data [J]. J Med Chem 2002, 45(13):2867-2876.
5. Volmer DA, Sleno L, Bateman K, et al. Comparison of MALDI to ESI on a triple quadrupole platform for pharmacokinetic analyses[J]. Anal Chem 2007, 79(23):9000-9006.
6. Bao KD, Li P, Qi LW, et al. Characterization of flavonoid metabolites in rat plasma, urine, and feces after oral administration of Semen Ziziphi Spinosae extract by HPLC-diode-array detection (DAD) and ion-trap mass spectrometry (MS(n)) [J]. Chem Pharm Bull 2009, 57(2):144-148.
7. Li Y, Duan J, Guo T, et al. In vivo pharmacokinetics comparisons of icariin, emodin and psoralen from Gan-kang granules and extracts of Herba Epimedii, Nepal dock root, Ficus hirta Yahl[J]. J Ethnopharmacol 2009, 124(3):522-529.
8. Tang J, Song X, Zhu M, et al. Study on the pharmacokinetics drug-drug interaction potential of Glycyrrhiza uralensis, a traditional Chinese medicine, with lidocaine in rats[J]. Phytother Res 2009, 23(5):603-607.
9. Lee JC, Bhora F, Sun J, et al. Dietary flaxseed enhances antioxidant defenses and is protective in a mouse model of lung ischemia-reperfusion injury[J]. Am J Physiol Lung Cell Mol Physiol 2008, 294(2):255-265.
10. Davin LB, Lewis NG Dirigent proteins and dirigent sites explain the mystery of specificity of radical precursor coupling in lignan and lignin biosynthesis[J]. Plant Physiol 2000, 123(2):453-462.
11. Li L, Pan Q, Han W, et al. Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing glutathione redox cycling[J]. Clin Cancer Res 2007, 13(22 Pt 1):6753-6760.
12. Liang Y, Hao H, Kang A, et al. Qualitative and quantitative determination of complicated herbal components by liquid chromatography hybrid ion trap time-of-flight mass spectrometry and a relative exposure approach to herbal pharmacokinetics independent of standards[J]. J Chromatogr A 2010, 1217(30):4971-4979.
13. Hao H, Cui N, Wang G, et al. Global detection and identification of nontarget components from herbal preparations by liquid chromatography hybrid ion trap time-of-flight mass spectrometry and a strategy[J]. Anal Chem 2008, 80(21):8187-8194.
14. Gong P, Cui N, Wu L, et al. Chemicalome and metabolome matching approach to elucidating biological metabolic networks of complex mixtures[J]. Anal Chem 2012, 84(6):2995-3002.
15. Yang Y, Engkvist O, Llinàs A, et al. Beyond size, ionization state and lipophilicity: influence of molecular topology on ADMET properties for drug-like compounds[J]. J Med Chem 2012, 55(8):3667-3677.
16. Zheng C, Hao H, Wang X, et al. Diagnostic fragment-ion-based extension strategy for rapid screening and identification of serial components of homologous families contained in traditional Chinese medicine prescription using high-resolution LC-ESI-IT-TOF/MS: Shengmai injection as an example[J]. J Mass Spectrom 2009, 44(2):230-244.